OTC Markets OTCPK - Delayed Quote USD
Galera Therapeutics, Inc. (GRTX)
0.0250
+0.0015
+(6.38%)
At close: 3:52:58 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -0.5 | -2.3 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| Currency in USD | 12/31/2022 | 3/31/2023 | 6/30/2023 | 9/30/2023 |
|---|---|---|---|---|
| EPS Est. | -0.51 | -0.43 | -0.38 | -0.4 |
| EPS Actual | -0.58 | -0.5 | -0.48 | -0.33 |
| Difference | -0.07 | -0.07 | -0.1 | 0.07 |
| Surprise % | -14.81% | -16.35% | -26.88% | 16.92% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | -- | -- |
| Up Last 30 Days | -- | 1 | 2 | -- |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | 1 | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GRTX | -- | -- | -- | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
| Maintains | Citigroup: Neutral to Neutral | 8/29/2023 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 8/16/2023 |
| Downgrade | Piper Sandler: Overweight to Neutral | 8/10/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 7/17/2023 |
| Maintains | HC Wainwright & Co.: Buy | 3/22/2023 |
| Initiated | Piper Sandler: Overweight | 2/21/2023 |
Related Tickers
032790.KQ Bngt Co.,Ltd.
1,261.00
-0.71%
NLSP NLS Pharmaceutics AG
1.5000
+1.35%
STTK Shattuck Labs, Inc.
0.8379
-1.57%
AMPE Ampio Pharmaceuticals, Inc.
0.0217
-0.23%
RLYB Rallybio Corporation
0.2970
+0.47%
ENTA Enanta Pharmaceuticals, Inc.
5.67
+1.25%
PBLA Panbela Therapeutics, Inc.
0.2900
+3.57%
CTNM Contineum Therapeutics, Inc.
4.5200
-4.64%
IVA Inventiva S.A.
3.7700
-1.57%
NXTC NextCure, Inc.
0.4190
-0.24%